CPD Courses

VISITECT® CD4 Advanced Disease Test

Training Course AccuBio

About the CPD course

In people living with HIV; CD4 remains the best measure of immune status. Early identification of advanced HIV disease; defined by WHO as less than 200 CD4+ T cells/mL; is important for identifying major opportunistic infections (OI) like tuberculosis and cryptococcal meningitis. VISITECT® CD4 Advanced Disease is a rapid; visually read; lateral flow assay; from a small drop of blood it reports if the patient’s level is below 200 CD4+ T cells/mL. The test is for professional use only and is an ideal solution for same-day CD4 testing in decentralised settings at the point-of-care or primary healthcare level.

CPD Provider

AccuBio

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AccuBio

AccuBio

We are based in Alva, United Kingdom. Developing, manufacturing, and commercializing in-vitro diagnostic test systems worldwide to enhance global health.

Get industry-related content straight to your inbox

By signing up to our site you are agreeing to our privacy policy